﻿<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Explor BioMat-X</journal-id>
<journal-id journal-id-type="publisher-id">EBMX</journal-id>
<journal-title-group>
<journal-title>Exploration of BioMat-X</journal-title>
</journal-title-group>
<issn pub-type="epub">2996-9476</issn>
<publisher>
<publisher-name>Open Exploration Publishing</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.37349/ebmx.2025.101335</article-id>
<article-id pub-id-type="manuscript">101335</article-id>
<article-categories>
<subj-group>
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4817-0627</contrib-id>
<name>
<surname>Dabrowski</surname>
<given-names>Alexandra C.</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
<xref ref-type="fn" rid="afn1">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-5194-0877</contrib-id>
<name>
<surname>Logan</surname>
<given-names>Alexandria R.</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
<xref ref-type="fn" rid="afn1">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rayaji</surname>
<given-names>Rameshwari</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2489-4275</contrib-id>
<name>
<surname>Rodriguez</surname>
<given-names>Brianna</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3344-337X</contrib-id>
<name>
<surname>Cai</surname>
<given-names>Li</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6184-3103</contrib-id>
<name>
<surname>Vazquez</surname>
<given-names>Maribel</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Singh</surname>
<given-names>Ajay Vikram</given-names>
</name>
<role>Academic Editor</role>
<aff>German Federal Institute for Risk Assessment (BfR), Germany</aff>
</contrib>
</contrib-group>
<aff id="I1">Department of Biomedical Engineering, Rutgers, The State University of New Jersey-New Brunswick, Piscataway, NJ 08854, US</aff>
<author-notes>
<fn id="afn1" fn-type="equal">
<label>†</label>
<p>The authors contributed equally to this work.</p>
</fn>
<corresp id="cor1">
<bold>
<sup>*</sup>Correspondence:</bold> Maribel Vazquez, Department of Biomedical Engineering, Rutgers, The State University of New Jersey-New Brunswick, 599 Taylor Road, Piscataway, NJ 08854, US. <email>mv582@soe.rutgers.edu</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>04</month>
<year>2025</year>
</pub-date>
<volume>2</volume>
<elocation-id>101335</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>12</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>03</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2025.</copyright-statement>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Aim:</title>
<p id="absp-1">This study evaluated the impact of retinal extracellular matrix (ECM) and key biomaterial substrates on the motility of transplantable retinal cells with genomic manipulation, using the therapeutic molecule, Topoisomerase II beta (Top2b), as a model.</p>
</sec>
<sec>
<title>Methods:</title>
<p id="absp-2">Tests first applied in ovo electroporation to examine the effects of a pharmacological Top2b inhibitor (ICRF-193) on progenitor motility and development of embryonic retina. Complementary qRT-PCR tests measured changes in select cadherin molecules in response to treatment. In vitro transfection produced cultured retinal progenitor cell groups with Top2b overexpression and Top2b knockdown. Differences in the adhesion and motility of Top2b altered groups, compared to wildtype cells, were measured upon biomaterial substrates used in emerging transplantation matrixes.</p>
</sec>
<sec>
<title>Results:</title>
<p id="absp-3">Data illustrated significant differences in the number and spacing of retinal ganglion cells when retina was treated with ICRF-193, as well as downregulation of several key cadherin molecules. Cultured retinal progenitors with Top2b knockdown and Top2b overexpression exhibited different expression of chemotactic receptors, adhesion parameters, and modalities of migration upon substrates of laminin, poly-L-lysine, and collagen IV. Significant changes in cell morphology and surface area were also measured compared to wildtype cells.</p>
</sec>
<sec>
<title>Conclusions:</title>
<p id="absp-4">Corroborating in vivo and in vitro data support Top2b as a therapeutic target for retinal progenitor motility but indicate significant differences in the migration of Top2b altered cells upon substrates used in transplantation. These data highlight the therapeutic advantages of bioinspired materials developed to aid the motility of replacement cells with modified genetic expression to improve transplantation outcomes across the nervous system.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ICRF-193</kwd>
<kwd>ganglion cell layer</kwd>
<kwd>cadherins</kwd>
<kwd>collective motility</kwd>
<kwd>laminin</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p id="p-1">Adult vision loss is a growing and worldwide public health challenge with degenerative disorders, such as age-related macular degeneration, diabetic retinopathy, and glaucoma, expected to increase dramatically within aging populations [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Regenerative medicine offers promising strategies to treat adult retinal disorders through cell replacement therapy, where specialized biomaterials are used to transplant groups of donor stem-like cells to replace degenerated or dysfunctional neurons (reviewed in [<xref ref-type="bibr" rid="B3">3</xref>]). Contemporary usage of hydrogels [<xref ref-type="bibr" rid="B4">4</xref>–<xref ref-type="bibr" rid="B6">6</xref>], decellularized matrix [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>], and scaffolds [<xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B11">11</xref>] for donor cell delivery has significantly increased cell survival to enable quantitative bioengineering study of transplantation processes. In complement, replacement cells have become increasingly genetically manipulated to replicate desired properties of highly specialized neurons [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. Indeed, modern genomic editing has achieved selective gene expression within native cell groups to alleviate the well-known challenges of immune rejection and inadequate differentiation reported when adding new genetic material [<xref ref-type="bibr" rid="B14">14</xref>]. While this novel biotechnology provides newfound opportunities for therapeutic genomic targets, the downstream implications of gene editing, silencing, or manipulation on cell-cell and cell-matrix behaviors remain underexplored. Significantly, changes to these fundamental cell processes can be positively or negatively amplified when combined with matrix substrates used in transplantable biomaterials.</p>
<p id="p-2">Bioinspired materials designed to support replacement cells with specialized gene expression hold great promise for transplantation therapy [<xref ref-type="bibr" rid="B15">15</xref>], as the donor cells must adhere and migrate within the delivery matrix prior to their infiltration into damaged host [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>]. Our group has previously applied in vitro modeling to report that principal matrix proteins can directly impact cell communication [<xref ref-type="bibr" rid="B18">18</xref>], as well as stimulate collective and individual cell migration [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>]. Abilities to regulate distinct and/or hybrid modalities of cell cohesion and motility using biomaterials are exciting tools with which to promote the infiltration of replacement cells.</p>
<p id="p-3">Transplantation in the retina is an excellent model to develop bioinspired materials in synergy with genomic editing because the eye is a self-contained and largely immune-privileged system. Moreover, practical surgical procedures in the eye have been developed for a variety of animal models [<xref ref-type="bibr" rid="B21">21</xref>], while established imaging techniques facilitate monitoring of donor cell behaviors over time [<xref ref-type="bibr" rid="B22">22</xref>]. The human retina is a multi-laminated structure that is populated by interconnected networks of neurons and glia across three principal layers, as per <xref ref-type="fig" rid="fig1">Figure 1</xref>. In brief, light refracted into the eye is first absorbed by rod and cone photoreceptors of the outer nuclear layer (ONL) that synapse with secondary neurons of the inner nuclear layer (INL), i.e., horizontal, amacrine, and bipolar cells shown. Secondary neurons then synapse with retinal ganglion cells of the ganglion cell layer (GCL), which are projection neurons that deliver photochemical signals to the brain through the optic nerve. Importantly, retinal homeostasis is facilitated by Muller glia cells that maintain osmotic and ionic balance for neuronal synapse [<xref ref-type="bibr" rid="B23">23</xref>] as well as by the inner (IPL) and outer plexiform layers (OPL) that serve as retinal extracellular matrix (ECM) to facilitate synaptic communication across the specialized groups of neurons [<xref ref-type="bibr" rid="B24">24</xref>].</p>
<fig id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p id="fig1-p-1">
<bold>Schematic of the healthy adult retina</bold>. The human retina is a complex structure composed of specialized retinal neurons and Muller glia (MG) connected across three synaptic layers. The retinal pigment epithelium [<xref ref-type="bibr" rid="B9">9</xref>] is a single cell layer that lies between the neuroretina and choroid. Rod and cone photoreceptors interdigitate with RPE (retinal pigmented epithelium) but reside in the outer nuclear layer (ONL). Photoreceptors synapse across the outer plexiform layer (OPL) with secondary neurons in the inner nuclear layer (INL), i.e., the horizontal, amacrine, and bipolar cells shown. These secondary neurons then synapse across the inner plexiform layer (IPL) to communicate with retinal ganglion cells within the ganglion cell layer (GCL). These final, projection neurons transmit signals to the brain through the optic nerve. Modified from [<xref ref-type="bibr" rid="B25">25</xref>], CC-BY 4.0</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g001.tif" />
</fig>
<p id="p-4">Novel biomaterials are heavily investigated for the transplantation of retinal ganglion cells in the GCL [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>] significant to progressive vision loss in adults. Recent genomic targets for these cell replacements include DNA topoisomerases that regulate conformational changes in DNA topology during cell growth to affect migration, differentiation, and synapse (reviewed in [<xref ref-type="bibr" rid="B28">28</xref>]). The Topoisomerase II beta (Top2b) enzyme is important to the transcriptional regulation of genes needed in retinal development and has become an attractive regenerative target for its impacts on progenitor motility [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Independent studies have demonstrated the mechanistic role of Top2b in the regulation of migration-targeted pathways, including via Rho GTPase signaling, and integrin-mediated adhesion (reviewed in [<xref ref-type="bibr" rid="B30">30</xref>–<xref ref-type="bibr" rid="B32">32</xref>]). The previous study from our group has demonstrated involvement of Top2b in the proper development and survival of postmitotic, retinal neurons [<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>], suggesting that biomaterials developed to guide the adhesive and migratory behaviors of donor cells with modified Top2b expression have novel potential to promote the infiltration of replacement cells.</p>
<p id="p-5">This study examined how changes in the expression of Top2b impacted in vivo motility in developing retina as well as in vitro cell migration upon transplantable matrix and protein substrates. Pharmacological inhibition of Top2b was observed to decrease cell-to-cell communication and cell alignment within GCL layers at early differentiation stages in embryonic day 6 (E6). Cultured replacement cells with persistent Top2b knockdown (Top2b-KD) and Top2b overexpression (Top2b-OE) exhibited varied expression of chemotactic receptors and significant differences in migration. Data additionally illustrated preferential attachment of Top2b-KD and Top2b-OE cell groups upon different matrix components, as measured by changes in the cell surface area and adhesive morphology. These corroborating results highlight the advantages of developing bioinspired materials to guide the infiltration of cell replacements with modified gene expression to improve transplantation outcomes.</p>
</sec>
<sec id="s2">
<title>Materials and methods</title>
<sec id="t2-1">
<title>Chick embryos</title>
<p id="p-6">Fertilized specific pathogen-free (SPF) white leghorn chicken eggs (Charles River Laboratories, Wilmington, MA, USA) were maintained at room temperature (25°C) for 2 h before being placed in an incubator at 37.5°C with 60% humidity. The eggs were incubated for 96–100 hr (~4 days) to procure chick embryos at developmental stage embryonic day 1–4 (E1–E4) or Hamburger-Hamilton stages (HH) 12–22.</p>
</sec>
<sec id="t2-2">
<title>In ovo retinal injections and electroporation of reagents</title>
<p id="p-7">Subretinal injections and in ovo electroporation of embryos at E4 were performed as per the literature [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>] and shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Briefly, the amnion and vitelline membranes were carefully removed with fine, sterile forceps to expose the embryo. For retinal injection, capillary glass pipettes (1.4 mm diameter; Drummond Scientific Company, Broomall, PA, USA, 2-000-001) were pulled with a microelectrode puller to get a 20 mm taper tip. The tip was broken under a dissecting microscope using a tweezer to obtain a tip opening approximately 0.1 μm in diameter. The microneedle was loaded with a mixture of 500 μM of the Top2b inhibitor ICRF-193 (Santa Cruz Biotechnology, Dallas, TX, USA, 21416-68-2) dissolved in HIBERNATE<sup>®</sup> media (Gibco, Thermo Fisher Scientific, Waltham, MA, USA, A1247501). Many contemporary studies have applied the commercial molecule tested to inhibit both Top2b and Top2a [<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>]. However, our study focused on cell migration, which is a cell process known to be regulated by Top2b rather than Top2a [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>]. Further, Top2a expression is mainly observed in proliferating cells, rather than in the post-mitotic cells used in this study [<xref ref-type="bibr" rid="B41">41</xref>]. Hence, the inhibitory effect of ICRF-193 in postmitotic cells that undergo migration is largely specific to Top2b. This commercial inhibitor was chosen because of its widespread usage in both in vivo and in vitro projects [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>]. Further, the concentration used in testing was selected to corroborate published studies [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>].</p>
<fig id="fig2" position="float">
<label>Figure 2</label>
<caption>
<p id="fig2-p-1">
<bold>Summary of in ovo retinal injection and electroporation used to deliver pharmacology.</bold> (<bold>A</bold>) A microneedle is loaded with the Top2b inhibitor (blue) within a GFP plasmid solution for visualization. (<bold>B</bold>) The microneedle is inserted within an E4 chick embryo. (<bold>C</bold>) Electroporation of the eye is performed using a pulse generator (arrows point to electrodes) to (<bold>D</bold>) deliver reagent within the retina. Scale bar = 1 mm. E4: embryonic day 4</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g002.tif" />
</fig>
<p id="p-8">The reporter pCAG-GFP plasmid solution with a concentration ranging 3–6 μg/μL and 0.2 μL of fast green (0.025%) (MilliporeSigma, Burlington, MA, USA, 2353-45-9) was attached to a 0.1 mL syringe (Hamilton Company, Reno, NV, USA, Gastight Model 1710) for visual confirmation of solution delivery and mounted onto a manual micromanipulator (WPI, Sarasota, FL, M3301-M3-R) with a small piece of masterflex silicone tubing on the syringe needle. The mixture was injected directly into the embryonic subretinal space, and the embryo was electroporated with 5 square pulses of 15 V for 50 ms with 950 ms intervals using a pulse generator (BTX Harvard Apparatus, Boston, MA, USA, ECM 830). GFP expression was used as a marker to locate retinal tissue affected by the Top2b inhibitor ICRF-193.</p>
</sec>
<sec id="t2-3">
<title>Processing and sectioning of retinal tissue</title>
<p id="p-9">Chick embryos post-E4 retinal injections were harvested from the shell and euthanized by decapitation at E6 and E12. The eyes were harvested and transferred to a petri dish of cold 1× PBS (phosphate buffer saline; Thermo Fisher Scientific, Waltham, MA, USA, BP3994). The retinal pigmented epithelium [<xref ref-type="bibr" rid="B9">9</xref>] was carefully dissected using fine forceps, and the cornea, lens, and vitreous were removed. The retinal tissue was then fixed in 4% paraformaldehyde (PFA) (Thermo Fisher Scientific, Waltham, MA, USA, AA433689L) in 1× PBS overnight at 4°C, followed by three times cold PBS wash for 10 min at 4°C and then infiltrated overnight in 30% sucrose (in 1× PBS). Embryos injected with the GFP-reporter plasmid constructs were verified for successful transfection via retinal inspection with a fluorescent dissection microscope (Leica Microsystems, Wetzlar, Germany, Leica MZ16FA), before embedding the retinal tissues in a solution of optimal cutting temperature compound (OCT, Electron Microscopy Sciences, Hatfield, PA, USA). Tissues embedded in OCT were stored at –80°C until ready for sectioning. Embedded tissue samples were sectioned using a cryostat to obtain sections of 12-μm-thickness (Thermo Fisher Scientific, Waltham, MA, USA, 0620E) and mounted on super-frost slides (Thermo Fisher Scientific, Waltham, MA, USA, 12-550-15S24), followed by air-drying. Immunohistochemistry using cell-specific markers was performed immediately afterwards.</p>
</sec>
<sec id="t2-4">
<title>Immunohistochemistry of retinal tissue</title>
<p id="p-10">Immunostaining was performed using Shandon Slide Rack (Thermo Fisher Scientific, Waltham, MA, USA). Slides containing tissue sections were placed on a warming plate for 15 min to remove excess OCT medium (Fisher Healthcare, Waltham, MA, USA, 23-730-571). Sections were then fixed with drops of 4% PFA, followed by 3 washes of 1× PBS for 10 min. Retinal sections were incubated for 1 hr in blocking solution [0.05% Triton X-100, 3% BSA, 10% goat serum or donkey serum (VWR, Radnor, PA, USA, 80054-446), in 1× PBS] at room temperature, followed by primary antibody overnight. Primary antibodies and dilutions used were as follows: mouse anti-Brn3a (1:200; MilliporeSigma, Burlington, MA, USA, AB5945) mouse, mouse Tuj1 (1:1,000; Abcam, Cambridge, UK, ab18207), mouse Calretinin (1:2,000; Chemicon, Rolling Meadows, Illinois, USA, MAB1568) and mouse Parvalbumin (1:1,000; Millipore, Burlington, MA, USA, MAB1572). Opposing control slides were not applied with any primary antibody. All slides were then washed with 1× PBS followed by the application of a secondary antibody carrying fluorescence from the appropriate host (mouse 594 nm, 1:300 dilutions; Jackson Immuno Research, West Grove, PA, USA, 715-585-150) for 1 hr. The slides were washed with 1× PBS and air dried, and a coverslip was placed on top to seal the samples using Cytoseal-60 (Thermo Fisher Scientific, Waltham, MA, USA, 50-252-72) for image analysis.</p>
</sec>
<sec id="t2-5">
<title>Cultured retinal progenitor cells</title>
<p id="p-11">Retinal progenitor cells were commercially purchased (R28; Kerafast, Boston, MA, USA, EUR201) and cultured for testing. Growth media was prepared under sterile conditions using 89% Dulbecco’s Modified Eagle’s Medium (DMEM; ATCC, Manassas, VA, USA, 30-2002), 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA, USA, 26140087), and 1% Pen-Strep (Gibco, Thermo Fisher Scientific, Waltham, MA, USA, 15-140-122). Cells were grown in ventilated, T-25 flasks (VWR, Radnor, PA, USA, 29185-300) for 4–5 days until near confluency. Growth medium was then aspirated, and cells were incubated with 3 mL of Trypsin (Gibco, Thermo Fisher Scientific, Ontario, CA, 25200-072) at 37°C for 5 min to dislodge adherent cells. Trypsin was then neutralized with 8 mL of R28 media and cells were pipetted into a 15 mL centrifuge tube and centrifuged at 1,500 rpm for 5 min. The supernatant was aspirated, and the cell pellet was resuspended in 3 mL of fresh R28 growth medium. The cells were then re-seeded in a new T-25 flask at 10<sup>6</sup> cells per mL and incubated at 37°C and 5% CO<sub>2</sub> until confluency.</p>
</sec>
<sec id="t2-6">
<title>Production of Top2b-KD and Top2b-OE cells</title>
<p id="p-12">A series of 24-well plate (VWR, Philadelphia, PA, USA, 29442-044) were coated with 15 μg/mL laminin (LM) (Corning, NY, USA, 354239) and incubated for 24 hr. Confluent cells were plated at a density of 0.5 × 10<sup>5</sup> cells/mL with MEM media. Cells were incubated for 24 hr and allowed to attach. Transductions were performed using a lentiviral vector (Origene, Rockville, MD, USA, TL516385V, labeled with GFP) with a multiplicity of infection (MOI) of 1.5. The lentiviral vector was mixed with the medium, added to the cells, and incubated for 24 hr. The media was replaced after 24 hr and cells were fixed with 4% PFA (Thermo Fisher Scientific, Waltham, MA, USA, AA433689L) and stained for the desired receptor expression. Transfections were performed using the Lipofectamine™ 3000 Transfection Kit (Thermo Fisher Scientific, Carlsbad, CA, USA, L3000015, labeled with GFP). The Lipofectamine 3000 agent was diluted in MEM media. The master mix was prepared by diluting the DNA (VectorBuilder, Chicago, IL, USA, VB900007-6027zju) with MEM media and adding the P3000 reagent and was incubated for 10–15 min. The master mix was added to the cells and incubated for 4 days. Live transfected cells were then selected for antibiotic resistance using a 2.5 mg/mL solution of puromycin dihydrochloride (Gibco, Thermo Fisher Scientific, Waltham, MA, USA, A1113803), as per <xref ref-type="sec" rid="s-suppl">Figure S1</xref>.</p>
</sec>
<sec id="t2-7">
<title>Immunocytochemical staining of cell reporters</title>
<p id="p-13">Cells were seeded in 24-well plates (VWR, Philadelphia, PA, USA, 29442-044) at a concentration of 2.5 × 10<sup>5</sup> cells/mL and allowed to attach for 24 hr. Solutions of media from each well were removed, wells were washed 3 times with Dulbecco’s phosphate-buffered saline (DPBS; Sigma-Aldrich, Allentown, PA, USA, D8537), and cells were fixed with cold PFA (4%) for 5 min. Then, wells were washed with DPBS for 5 min twice at room temperature. Blocking buffer solution (0.05% Triton X-100, 2% donkey serum, and 3% BSA in DPBS) was added to each well for 15 min at room temperature. Following, wells were washed twice with DPBS for 2 min, and a primary antibody for the receptors was added to each well for overnight incubation: CXC chemokine receptor 4 (CXCR4; Invitrogen, Carlsbad, CA, USA, PA5-19856), fibroblast growth factor receptor (FGFR1; Invitrogen, Carlsbad, CA, USA, PA5-104788), and vascular endothelial growth factor receptor (VEGFR1; Proteintech, Rosemont, IL, USA, 13687-1-AP). The next day, each well was washed 3 times with 1× DPBS for 2 min, followed by the addition of secondary antibodies (Alexa Fluor 647 AffiniPure; ImmunoResearch Laboratories, Inc., West Grove, PA, USA, 711-605-152) 1 hr at room temperature. Wells were washed 3 times with 1× DPBS for 2 min before addition of DAPI (1:1,000; Thermo Fisher Scientific, Carlsbad, CA, USA, D1306) into each well for 5 min at room temperature. Each well was washed with DPBS 3 times for 2 min.</p>
</sec>
<sec id="t2-8">
<title>Transwell assays and chemotactic agents</title>
<p id="p-14">Boyden chamber assays (Sigma-Aldrich, St. Louis, MO, USA, ECM506) were used to examine the motility of each cell group toward a given concentration of different growth factors. Cells were seeded in the upper chamber of the well assay and allowed to settle on the upper surface of the membrane overnight. Growth factor solutions were then added to the media in the lower reservoir, and cells were left to migrate for 6 hr to through the transwell membrane, as described previously by our group and many others (Reviewed in [<xref ref-type="bibr" rid="B44">44</xref>]).</p>
<p id="p-15">Transwell inserts used a polyester (PET) membrane (VWR, Radnor, PA, USA, 89235-020) of 10 μm thickness and 8.0 μm pore size. Approximately 600 μL of each growth factor vascular endothelial growth factor (VEGF; R&amp;D Systems, Minneapolis, MN, USA, 564-RV), fibroblast growth factor-8 (FGF-8; Invitrogen, Carlsbad, CA, USA, PHG0184), and stromal derived factor 1-a (SDF-1a; Sigma Aldrich, St. Louis, MO, USA, SRP3276) was added to the bottom of separate transwell assays. Cells were seeded on the membrane at a concentration of 2.5 × 10<sup>5</sup> cells/mL within media at 5% CO<sub>2</sub> and 37°C and left to incubate for 6 hr. After incubation, cells remaining on the top membrane were removed using a wet cotton swab. Control cells were stained with calcein-AM (Thermo Fisher, Burlington, ONT, CA, C1430) and reconstituted in PBS. Only live, fluorescent cells validated via optical microscopy were used for experiments.</p>
<p id="p-16">A parameter called the Cell Migration Index, CMI, was defined to numerically compare the results of motile cells in response to different chemoattractants and control experiments (medium only). CMI is defined as the ratio of average numbers of motile cells in response to an exogenous growth factor and the average number of motile cells in control wells, as shown:</p>
<p id="p-17">
<disp-formula id="eq1">
<label>(1)</label>
<mml:math id="m31f37">
<mml:msub>
<mml:mrow>
<mml:mtext>CMI</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mtext>control</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:math>
</disp-formula>
</p>
<p id="p-18">where the subscript i denotes the reagent in a specific well measured, <italic>n<sub>i</sub></italic> represents the number of motile cells in that well, and “<italic>N</italic><sub>control</sub>” is the average number of motile cells in control wells, per experiment.</p>
</sec>
<sec id="t2-9">
<title>Adhesion upon extracellular matrix and cell shape index</title>
<p id="p-19">Concentrations of 15 μg/mL LM (Corning, Corning, NY, USA, 354239), 20 μg/mL poly-L-lysine (PLL) (Sigma Aldrich, St. Louis, MO, USA, P4707), and 20 μg/mL collagen IV (CIV) (Sigma Aldrich, St. Louis, MO, USA, C6745-1ML) were used to coat inner surfaces of 24-well plates (Falcon Corning, Corning, NY, USA, 353047). Uncoated polystyrene wells (VWR, Philadelphia, PA, USA, 29442-044) were used as a control. The plate was incubated at 37°C for 1 hr. Then, cells were seeded at 45,000 cells/mL in a 24-well plate. Five images were taken of each well using brightfield. This was repeated every 4 hr for 24 hr. A parameter called Cell Shape Index (CSI) was used to evaluate cell morphology, defined as:</p>
<p id="p-20">
<disp-formula id="eq2">
<label>(2)</label>
<mml:math id="m33162">
<mml:mtext>CSI</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>4</mml:mn>
<mml:msup>
<mml:mrow>
<mml:mi>P</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mrow>
<mml:mi>A</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:math>
</disp-formula>
</p>
<p id="p-21">where <italic>P</italic> is the cell perimeter and <italic>A</italic> is the cell area. A CSI value of 0 represents a purely circular cell while a value of 1 represents a purely elongated cell [<xref ref-type="bibr" rid="B45">45</xref>].</p>
</sec>
<sec id="t2-10">
<title>Gene primers and PCR analyses</title>
<p id="p-22">Expression levels of four genes encoding adhesion molecules were measured using quantitative, real time polymerase chain reaction (qT-PCR): cadherin 2 (Cdh2), cadherin 6B (Cdh6B), cadherin 7 (Cdh7), and cadherin 8 (Cdh8). Primer specificity was verified using Basic Local Alignment Search Tool (BLAST), which confirmed the selected forward and reverse primers listed. A FASTA sequence of desired species specific (<italic>Gallus gallus</italic>) mRNA was acquired from NCBI nucleotide database as shown in <xref ref-type="table" rid="t1">Table 1</xref><italic>.</italic></p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<p id="t1-p-1">
<bold>Design of specific primers for qRT-PCR of chick retina</bold>
</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Name</bold>
</th>
<th>
<bold>PCR product (bp)</bold>
</th>
<th>
<bold>Primer sequence</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cdh2</td>
<td>426</td>
<td>Forward: AGCTGACCAACCTCCAACAG<break />Reverse: TGTACTTTCTCTCTGTCGAGCC</td>
</tr>
<tr>
<td>Cdh6B</td>
<td>269</td>
<td>Forward: CCCCCAGAGCACCTACCAAT<break />Reverse: ATCGAGGGTCCACGTGAGTA</td>
</tr>
<tr>
<td>Cdh7</td>
<td>319</td>
<td>Forward: GACCCTTCAGCGACATGACA<break />Reverse: TGTGCTGGATTCTGACTCTCC</td>
</tr>
<tr>
<td>Cdh8</td>
<td>289</td>
<td>Forward: TGGTGATTTGCGTAGCTTGTG<break />Reverse: TCTGTATGTAACCGGCCAACT</td>
</tr>
</tbody>
</table>
</table-wrap>
<p id="p-23">Primer pairs were selected based on PCR product size (200–300 bp) and analyzed using IDT’s oligo analyzer tool. Primers were examined for hairpin loop structures, high ∆G values and annealing temperature range T<sub>m</sub> values for specificity and reliability. Relative gene expression data were analyzed using the conventional 2<sup>–ΔΔCt</sup> (DDCT) method [<xref ref-type="bibr" rid="B46">46</xref>].</p>
</sec>
<sec id="t2-11">
<title>Imaging and analyses</title>
<p id="p-24">Microscopic images were analyzed using an upright fluorescence microscope (Zeiss Axio Imager A1) with a monochrome digital camera Axiocam MRM (Zeiss, Oberkochen, Germany). Images were acquired to confirm cell-specific markers in 549 nm, 594 nm, and 647 nm channels. Images were captured at the same exposure and threshold, and at the same intensity per condition. Cells that were modified to overexpress or knockdown Top2b expression were evaluated for CSI, surface area, and migration if they displayed a GFP tag after 24 hr of incubation. Each well was imaged five times, and ImageJ software was used to evaluate 5 cells per image for CSI, surface area, and migration distance. Fluorescing cells were counted using ImageJ.</p>
</sec>
<sec id="t2-12">
<title>Statistical analyses</title>
<p id="p-25">Each in vitro data set was collected from replicates using <italic>n</italic> = 4 per condition, with five images collected per well containing at least five cells per image. A Shapiro-Wilks test was performed to assess the normality of the data. Cell migration was analyzed with two-way ANOVA with Tukey’s post-hoc test. Surface area index and CSI were analyzed with two-way ANOVA with Dunnett’s post-hoc test. Cell receptor expression was evaluated using Kruskal-Wallis rank test with Dunn’s multiple comparisons post-hoc test. Significance was denoted as (*) <italic>p</italic> &lt; 0.05, (**) <italic>p</italic> &lt; 0.01, (***) <italic>p</italic> &lt; 0.001, and (****) <italic>p</italic> &lt; 0.0001.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="t3-1">
<title>Top2b inhibition delays the development and alignment of the ganglion cell layer</title>
<p id="p-26">The first set of tests examined the effects of pharmacological Top2b inhibition using the well-established chick model of retinal embryonic development [<xref ref-type="bibr" rid="B47">47</xref>]. Tests combined our previous methodology of in ovo retinal injection with electroporation to deliver ICRF-193, a known potent topoisomerase II inhibitor [<xref ref-type="bibr" rid="B48">48</xref>]. <xref ref-type="fig" rid="fig3">Figure 3</xref> depicts histological sections of developing chick retina at embryonic day E6 and E12, treated and untreated with the Top2b inhibitor ICRF-193. Images of E6 illustrate the nuclei (DAPI staining in blue) of neuronal cells within the outer (ONBL) and inner neuroblastic layer (INBL), which are early developmental stages of the ONL, INL, alongside the GCL. Tests first examined differences in the neuronal marker beta tubulin III (Tuj1), a structural component of the microtubule network expressed during the earliest stages of neuronal differentiation in the chick retina [<xref ref-type="bibr" rid="B49">49</xref>]. As shown (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3">3B</xref>), both the number and intensity of Tuj1<sup>+</sup> retinal cells (red) in the INBL were significantly reduced via Top2b inhibition compared to control retina. Top2b inhibition additionally disrupted cellular arrangement of the INBL layer at E6, as its thickness was significantly reduced compared to control and INBL cell arrangement depicted wide spacings not observed in control retina. Images gathered at the later differentiation stage of E12 illustrate nuclear staining of neuronal cells (DAPI in blue) within the developed retinal ONL, INL, and GCL. In addition, OPL and IPL separate the cell layers at this developmental stage, as marked. Data (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3">3D</xref>) illustrate no significant differences observed in the number of Tuj1<sup>+</sup> cells between Top2b-treated and control retinas at E12. Moreover, differences in the thickness of GCL layers were insignificant (as shown by arrows).</p>
<fig id="fig3" position="float">
<label>Figure 3</label>
<caption>
<p id="fig3-p-1">
<bold>Inhibition of Top2b delays the development and alignment of the ganglion cell layer (GCL).</bold> Representative fluorescence images of immunostained sections of chick embryonic retina treated with a commercial Top2b inhibitor (ICRF-193) against control at embryonic developmental day E6 and E12. Neurofilaments of the developing inner plexiform layer (IPL) were stained with anti-Tuj1 (<bold>A</bold>–<bold>D</bold>), and retinal ganglion cells were stained using anti-Brn3a (<bold>E</bold>–<bold>H</bold>). All cell nuclei were stained with DAPI (in blue). At E6, Tuj1<sup>+</sup> labeled processes of retinal ganglion cells (RGCs) in the control retinas (<bold>A</bold>), but its expression was widespread and reduced in the ICRF-193 treated sections (i.e., Top2b inhibited) (<bold>B</bold>). Brn3a<sup>+</sup> cells were located in the GCL of control retinas (<bold>E</bold>) but were more widely dispersed and formed grouped cell masses in the inner neuroblastic layer (INBL) and outer neuroblastic layer (ONBL) in ICRF-193 treated retinas. At E12 no significant differences (<bold>D</bold>) in Tuj1<sup>+</sup> expression or in (<bold>H</bold>) numbers of Brn3a<sup>+</sup> cells were observed. Arrowheads indicate Tuj1<sup>+</sup> or Brn3a<sup>+</sup> cells. Scale bar = 50 μm. E6, E12: embryonic day 6, day 12; GCL: ganglion cell layer; ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g003.tif" />
</fig>
<p id="p-27">Retinal slices were next examined for differences in expression of the marker Brn3a, a transcription factor critical to the differentiation of dendritic arbors that regulate function in retinal ganglion cells [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>]. Images at E6 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3">3F</xref>) reveal that Brn3a<sup>+</sup> cells (red) were located uniformly along the INBL in control retinas but observed to be unevenly dispersed along the INBL of Top2b-inhibited retina. Moreover, Brn3a<sup>+</sup> cells were highly clustered in ICRF-193 treated retinas, but not in control (denoted by arrows). By E12, however, Top2b-inhibited retinas and illustrated no significant differences in cell clustering within the GCL compared to control (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, <xref ref-type="fig" rid="fig3">3H</xref>).</p>
</sec>
<sec id="t3-2">
<title>Top2b inhibition disrupted calcium signaling across retinal ganglion cells</title>
<p id="p-28">Control and Top2b-inhibited retina were additionally studied for changes in the expression of calretinin and parvalbumin, two calcium-binding proteins that regulate calcium transport and neuronal excitability [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>]. <xref ref-type="fig" rid="fig4">Figure 4</xref> illustrates decreases in the expression of calretinin (red) across cells of the INBL between control and ICRF-193 treated retina at E6. As shown, decreased levels were observed along a significantly thinner INBL (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4">4B</xref>). However, no difference in calretinin expression or GCL thickness was observed by E12 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4">4D</xref>). Retinas stained for parvalbumin similarly showed lowered expression in cells of the INBL between control and ICRF-193 treated retina at E6. Moreover, arrows point to significant reduction of INBL thickness with lower expression of parvalbumin (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4">4F</xref>). By E12, however, changes in parvalbumin expression within the GCL were insignificant across control and treated retina (<xref ref-type="fig" rid="fig4">Figure 4G</xref>, <xref ref-type="fig" rid="fig4">4H</xref>).</p>
<fig id="fig4" position="float">
<label>Figure 4</label>
<caption>
<p id="fig4-p-1">
<bold>Top2b inhibition disrupted calcium signaling across retinal ganglion cells (RGCs).</bold> Representative fluorescence images of immunostained sections of chick embryonic retina treated and untreated with a commercial Top2b-inhibitor (ICRF-193) at E6 and E12. Neurofilaments were stained with anti-calretinin (<bold>A</bold>–<bold>D</bold>) and intracellular calcium-binding proteins with anti-parvalbumin (<bold>E</bold>–<bold>H</bold>; in red). Cell nuclei were stained with DAPI (in blue). At E6, calretinin-labeled neurofilaments in both the GCL and outer neuroblastic layer (ONBL) (<bold>A</bold>), while its expression was dramatically reduced in ICRF-193 treated (Top2b inhibited) retinas (<bold>B</bold>). Arrowhead indicates the inner neuroblastic layer (INBL). Parvalbumin expression was detected in the RGCs at the INBL-ONBL boundary (<bold>E</bold>, arrowheads), but not detected in ICRF-193 treated retina (<bold>F</bold>). At E12, the control and ICRF-193 treated samples showed no significant differences in calretinin (<bold>C</bold>, <bold>D</bold>) or parvalbumin expression (<bold>G</bold>, <bold>H</bold>). Scale bar = 50 μm. E6, E12: embryonic day 6, day 12; GCL: ganglion cell layer; ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g004.tif" />
</fig>
</sec>
<sec id="t3-3">
<title>Top2b inhibition downregulated cell adhesion molecules</title>
<p id="p-29">Our study next examined differences in the gene expression of adhesion molecules known to be significant to cell to cell signaling and GCL formation [<xref ref-type="bibr" rid="B54">54</xref>]. Tests applied qRT-PCR between developing retina treated and untreated with Top2b inhibitor ICRF-193 to illustrate relative changes in the gene expression of four critical cadherin molecules in E6–E12 retina: Cdh2, Cdh6B, Cdh7, and Cdh8. <xref ref-type="fig" rid="fig5">Figure 5</xref> illustrates that levels of gene expression for all cadherin molecules were lower for Top2b-treated retina than control from E6–E10. However, the relative expression of Cdh2, Cdh6B, Cdh7, and Cdh8 was insignificant (<italic>p</italic> &gt; 0.05) between control and Top2b-inhibited retina by E12.</p>
<fig id="fig5" position="float">
<label>Figure 5</label>
<caption>
<p id="fig5-p-1">
<bold>Relative expression of genes for cadherin molecules as determined by qRT-PCR using the 2<sup>–ΔΔCt</sup> (DDCT) method.</bold> Relative expressions of (<bold>A</bold>) Cdh2, (<bold>B</bold>) Cdh6B, (<bold>C</bold>) Cdh7, and (<bold>D</bold>) Cdh8 are shown at E6 through E12 for embryonic chick retina treated with a commercial Top2b inhibitor (ICRF-193) against control. E6–E12: embryonic day 6–12</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g005.tif" />
</fig>
</sec>
<sec id="t3-4">
<title>Cultured Top2b-KD and Top2b-OE cell groups produced different expression levels of chemotactic receptors</title>
<p id="p-30">Experiments next manipulated a heterotypic, retinal progenitor cell line previously reported to contain a majority of retinal ganglion cells [<xref ref-type="bibr" rid="B55">55</xref>] to develop two distinct cultured cell groups with different profiles of Top2b expression. Top2b-KD were produced through in vitro transfection with a Top2b-shRNA (shTop2b) plasmid construct previously established by our group [<xref ref-type="bibr" rid="B29">29</xref>], and Top2b-OE were developed via transfection with a plasmid encoding Top2b cDNA. Retinal progenitor cells with unaltered Top2b expression are denotes as wildtype or Top2b-WT. <xref ref-type="fig" rid="fig6">Figure 6</xref> illustrates Top2b-induced differences measured in the expression of 3 chemotactic receptors of interest to retina: VEGFR (receptor for VEGF ligand), FGFR (receptor for FGF-8 ligand), and CXCR4 (receptor for SDF-1a, also known as CXCL12). As seen, no significant differences (<italic>p</italic> &gt; 0.05) were measured in the expression of VEGFR between Top2b-WT, Top2b-KD, and Top2b-OE cell groups. However, expression of FGFR was significantly higher for Top2b-WT than Top2b-KD (<italic>p</italic> &lt; 0.01), while FGFR expression of Top2b-KD cells was not significantly different against Top2b-OE (<italic>p</italic> &gt; 0.05). By contrast, Top2b-OE cells exhibited dramatic increases in the expression of CXCR4, with average intensity values that were 2.5× higher than Top2b-WT (<italic>p</italic> &lt; 0.05). VEGFR and FGFR expressions in Top2b-OE cells were only slightly higher than Top2b-WT (<italic>p</italic> &gt; 0.05).</p>
<fig id="fig6" position="float">
<label>Figure 6</label>
<caption>
<p id="fig6-p-1">
<bold>Cultured retinal progenitor cell groups with Top2b overexpression (OE) and knockdown (KD) illustrate altered expression of select chemotactic receptors compared to wildtype cell groups with no Top2b manipulation (WT).</bold> Cell groups illustrated significant differences in the expression of selected chemotactic receptors: vascular endothelial growth factor receptor (VEGFR1), fibroblast growth factor receptor (FGFR1), and c-x-c chemokine receptor 4 (CXCR4, receptor for the stromal cell-derived factor 1, SDF-1a, ligand). Statistical significance across the cell groups is denoted by <italic>p</italic>-value: * &lt; 0.05, ** &lt; 0.01, **** &lt; 0.0001 as via two-way ANOVA tests followed by Dunnett’s post-hoc test</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g006.tif" />
</fig>
</sec>
<sec id="t3-5">
<title>Cultured Top2b groups exhibited different migratory behaviors to selected cytokines</title>
<p id="p-31">Top2b-KD, Top2b-OE, and Top2b-WT cell groups were next exposed to external growth factors to examine the effects of Top2b expression on chemotaxis. Cell migration was evaluated using the Cell Migration Factor, CMI (<xref ref-type="disp-formula" rid="eq1">Eq. 1</xref>), which normalized the number of motile cells of the Top2b-WT group towards the media only condition (no added growth factors, CMI = 1.0). <xref ref-type="fig" rid="fig7">Figure 7</xref> shows that Top2b-WT cells migrated with a lower CMI value to FGF than to media control (<italic>p</italic> &lt; 0.05), with a larger CMI value to VEGF relative to media control (<italic>p</italic> &lt; 0.05). Cells of the Top2b-WT group exhibited migration with comparable CMI between SDF-1a and the media control (<italic>p</italic> &gt; 0.05). Motile Top2b-KD cells produced lower CMI values than Top2b-WT cells, with a CMI value of 0.02 ± 0.058 compared to media control. Top2b-KD cells migrated in lower numbers to all growth factors studied, with a CMI of 0.13 ± 0.155 to FGF (<italic>p</italic> &lt; 0.05), CMI of 0.15 ± 0.295 to VEGF (<italic>p</italic> &lt; 0.05), and CMI of 0.08 ± 0.185 to SDF-1a (<italic>p</italic> = 0.05). Lastly, smaller total numbers of Top2b-OE cells migrated toward media control than those of the Top2b-WT cell group, with a CMI value of 0.56 ± 0.42. Top2b-OE cells migrated in higher numbers than Top2b-KD cells but in lower numbers than Top2b-WT cells to all growth factors relative to media control. Motile Top2b-OE cells displayed an average CMI of 0.19 ± 0.009 to FGF (<italic>p</italic> &lt; 0.01), CMI of 0.32 ± 0.216 to VEGF (<italic>p</italic> &lt; 0.05), and a CMI of 0.35 ± 0.151 to SDF-1a (<italic>p</italic> &lt; 0.05).</p>
<fig id="fig7" position="float">
<label>Figure 7</label>
<caption>
<p id="fig7-p-1">
<bold>Top2b manipulation altered the measured chemotactic migration of cultured progenitor cell groups.</bold> The migration of cells with Top2b overexpressed (OE) and knockdown (KD) was measured against wildtype cells without manipulation, Top2b-WT (WT). Data is represented using the cell migration index, CMI, which normalized the number of motile cells by the number of WT motile cells to the control (media solution only). Statistical significance is denoted by <italic>p</italic>-value: * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001, **** &lt; 0.0001 as per Kruskal-Wallis with Dunn’s post-hoc test</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g007.tif" />
</fig>
</sec>
<sec id="t3-6">
<title>Top2b targeting induced differences in cell matrix adhesion</title>
<p id="p-32">The final set of experiments measured morphological differences between Top2b-KD, Top2b-OE, and Top2b-WT cell groups attached upon LM, PLL, CIV, and polystyrene (PST, used as control). These materials were selected for study because they (a) have each been well studied in mechanisms of cell adhesion [<xref ref-type="bibr" rid="B56">56</xref>], (b) are components of many contemporary biomaterials [<xref ref-type="bibr" rid="B26">26</xref>], and (c) have been examined previously by many groups with retinal progenitors for applications in transplantation [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B57">57</xref>].</p>
<p id="p-33">Data represents cell morphology using the parameter of CSI commonly applied to denote varying levels of cell elongation significant to functional matrix adhesion [<xref ref-type="bibr" rid="B58">58</xref>]. <xref ref-type="fig" rid="fig8">Figure 8A</xref> shows that average CSI values of Top2b-WT cells were observed to decrease over 24 hr for all surface polymers used. As seen (<xref ref-type="fig" rid="fig8">Figure 8A-1</xref>), values of CSI upon PST (as control) were highest immediately after plating, with an initial value of 0.95 ± 0.06 that decreased to a minimum value of 0.49 ± 0.09 at 24 hr. CSI of Top2b-WT cells adhered upon CIV followed a similar pattern, with a maximum value of 0.87 ± 0.05 after plating and a minimum CSI of 0.44 ± 0.11 at 24 hr. By contrast, cells of the Top2b-WT group adhered upon LM with an initial CSI of 0.86 ± 0.09, but then decreased sharply after 12 hr. The CSI of these cells upon LM reached a minimum of 0.36 ± 0.15 after 24 hr. Lastly, the CSI values of Top2b-WT cells adhered upon PLL illustrated the largest and sharpest decrease in values, with a maximum of 0.77 ± 0.09 upon plating and a minimum of 0.36 ± 0.08 after 24 hr. In all cases, groups of Top2b-WT cells exhibited large changes in adhesion within the first 12 hr of overnight attachment, and illustrated small changes in the proceeding 12 hr. Statistical significance is shown per time point against PST (used as control).</p>
<fig id="fig8" position="float">
<label>Figure 8</label>
<caption>
<p id="fig8-p-1">
<bold>Substrates stimulate different adhesion responses from progenitor cell groups with modified Top2b manipulation.</bold> Calculations for the Cell Shape Index (CSI) of retinal progenitors with wildtype Top2b (WT) expression (<bold>A1</bold>), Top2b overexpression (OE) (<bold>A2</bold>), and Top2b knockdown (KD) modified (<bold>A3</bold>) illustrate different morphologies upon substrate proteins of control (glass, polystyrene), laminin, poly-L-lysine (PLL), and collagen IV. Changes in cell surface area (SA) are similarly denoted for retinal progenitors with wildtype Top2b expression (WT) (<bold>B1</bold>), Top2b overexpression (OE) (<bold>B2</bold>), and Top2b knockdown (KD) (<bold>B3</bold>) upon the same substrate molecules. Statistical significance against control is denoted by <italic>p</italic>-value: * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001, **** &lt; 0.0001 as per two-way ANOVA followed by Tukey’s post-hoc test</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebmx-02-101335-g008.tif" />
</fig>
<p id="p-34">The adhesion of Top2b-KD cells exhibited similar patterns of adhesion upon PST (control) surfaces with average CSI values of ~0.95 for all conditions. CSI values decreased upon each matrix substrate over 24 hr, with the lowest CSI of 0.42 ± 0.15 measured upon PLL (<italic>p</italic> &lt; 0.05). In contrast to the group of Top2b-WT cells, adhesion of Top2b-KD cells upon LM illustrated slower changes over time. Further, adhesion of Top2b-OE cells displayed similarly decreasing values of average CSI upon matrix substrates but demonstrated a dramatic decrease for adhesion upon LM. As seen, while all CSI values approached 1.0 upon initial plating, the CSI of Top2b-OE cells upon LM decreased sharply after only 8 hr and reached a minimum value of 0.47 ± 0.09 after 24 hr (<italic>p</italic> &lt; 0.05). Top2b-OE cells also exhibited increased CSI during adhesion upon PLL and CIV compared to PST (control).</p>
<p id="p-35">Lastly, cell adhesion was assessed via changes in the average surface area of each cell group, as shown in <xref ref-type="fig" rid="fig8">Figure 8B</xref>. Top2b-WT cells exhibited the largest average surface area upon LM (<italic>p</italic> &lt; 0.05), with statistically insignificant changes (<italic>p</italic> &gt; 0.05) upon PLL or CIV (<xref ref-type="fig" rid="fig8">Figure 8B-1</xref>). By contrast, the highest average surface area of Top2b-KD cells was measured upon PLL (<italic>p</italic> &lt; 0.05) (<xref ref-type="fig" rid="fig8">Figure 8B-2</xref>) and highest upon PST for Top2b-OE cells (<xref ref-type="fig" rid="fig8">Figure 8B-3</xref>), with insignificant differences on all other surface matrices (<italic>p</italic> &gt; 0.05).</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p id="p-36">Regenerative medicine offers promising treatment for adults with degenerative vision loss through cell replacement therapy, which transplants donor stem cells to replace dysfunctional and apoptotic neurons. Contemporary replacement cells have become increasingly bio-engineered using genomic editing to recapitulate explicit responses of specialized retinal neurons [<xref ref-type="bibr" rid="B59">59</xref>]. How these novel, edited cells interact with the biomaterials developed for their transplantation is critical, as migratory responses upon and within the biomaterial initiate the infiltration of replacement cells needed within the retinal host. The current study evaluated how bioinspired materials can be developed to support the transplantation of cells with manipulated gene expression of Top2b as a model target for retinal cell replacements.</p>
<p id="p-37">Top2b has received renewed interest in transplantation therapy because of its well-established regulation of genes critical to the differentiation and motility of retinal progenitors [<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>]. Recent studies demonstrated that knock out models of Top2b resulted in the systemic death of both vertebrate and invertebrate animals [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B60">60</xref>], while selective deletion of Top2b was able to alter the lamination of developing retina in mice [<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>] and zebrafish [<xref ref-type="bibr" rid="B61">61</xref>]. This project first examined the impact of pharmacological Top2b inhibition on early retinal development (E6) using the commercial molecule ICRF-193, a known catalytic inhibitor widely used in cancer therapy [<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>]. Treatment with ICRF-193 produced lower numbers of cells in the retinal GCL, an overall thinner GCL layer with irregular cellular spacing, and reduced levels of differentiation (<xref ref-type="fig" rid="fig3">Figure 3</xref>). While ICRF-193 has been widely used as a Top2b inhibitor in prior studies, the molecule may exhibit partial activity against other topoisomerases (e.g., Top2a) to confound mechanistic interpretations. However, our study focused on the migration of postmitotic cells, which preferentially express Top2b, rather than Top2a [<xref ref-type="bibr" rid="B39">39</xref>–<xref ref-type="bibr" rid="B41">41</xref>]. Hence, the inhibitory effect of ICRF-193 in postmitotic cells that undergo migration is largely specific to Top2b. This effect is consistent with observed migration defects in Top2b knockout mice studies [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B34">34</xref>]. Moreover, Top2b inhibition reduced calcium signaling between cells within the GCL (<xref ref-type="fig" rid="fig4">Figure 4</xref>), suggesting dysregulation in neuronal signaling due to reduced cell interactions with plexiform layers. This comprehensive data highlights Top2b as a therapeutic target for cell replacement therapy with understudied impacts on cell-to-matrix interactions able to alter cell motility.</p>
<p id="p-38">Pharmacological inhibition of Top2b additionally downregulated expression of cadherin molecules significant to cell-to-cell cohesion (<xref ref-type="fig" rid="fig5">Figure 5</xref>). This result is novel because it points to the roles of cell-to-cell adhesion molecules in promoting different modalities of migration. De/differentiated cells are well-known to respond to external stimuli via collective behaviors, such as clustering and organoid formation [<xref ref-type="bibr" rid="B64">64</xref>–<xref ref-type="bibr" rid="B66">66</xref>] that can lead to collective migration. Downregulation of Top2b may, therefore, inadvertently promote individual cell migration, which may be beneficial or detrimental to the migration of replacement cells upon selected biomaterials for transplantation. Interestingly, few studies have considered the collective responses of replacement cells upon transplantation matrix or within adult host ECM [<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>]. These results validate the interplay of Top2b regulation with ECM components in retina, as each of these fundamental processes depends upon cell interactions with developing plexiform layers, which serve as retinal ECM for their constituent, structural proteins essential to synaptic connections between neurons. Our data highlights new opportunities for development and/or application of bioinspired materials able to attenuate or promote these behaviors to improve transplantation outcomes.</p>
<p id="p-39">As the effects of pharmacological inhibition were predictably depleted by later embryonic stages (in this study E12), we next examined effects of Top2b regulation in transfected cells to selected cytokines significant to retinal development [<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>]. Top2b-OE cells illustrated significantly higher expression of FGFR1 and CXCR4, while expression of all receptors in Top2b-KD cells was less than Top2b-WT (i.e., no Top2b modifications) cell groups (<xref ref-type="fig" rid="fig6">Figure 6</xref>). As expected, Top2b-KD cells were then observed to migrate in the lowest numbers towards all growth factors. However, Top2b-OE cells failed to exhibit higher migratory responses than the wildtype group (<xref ref-type="fig" rid="fig7">Figure 7</xref>) despite the higher expression of cognate cell receptors. We note that existing data support the specificity of Top2b knockdown and knockout in migration phenotypes [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>] and also address concerns about off-target effects. Future work will perform mechanistic study to explore Top2b rescue and downstream effectors. We hypothesize that this result is due to collective cell migration, where motile clusters with an average size larger than the pores of the transwell membrane were unable to migrate across the assay. Our group has previously reported the upregulation of cadherin in cultured wildtype progenitors with higher expression of CXCR4, as well as demonstrated the clustering and collective motility responses of de/differentiated retinal cells [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B71">71</xref>]. Our current results are consistent with published data and underscore future studies to apply our microfluidic devices to image clustered cell migration [<xref ref-type="bibr" rid="B20">20</xref>].</p>
<p id="p-40">Our final set of tests examined how Top2b regulation impacted cell adhesion upon substrates used for transplantable biomaterials, as Top2b-KD cells exhibited elongated morphology upon PLL while Top2b-OE cells exhibited the most elongation upon LM (<xref ref-type="fig" rid="fig8">Figure 8</xref>). The larger values of CSI measured from the different adhered cell groups suggest that modification of Top2b expression impacts the selection of constituent substrates needed to develop biomaterials that promote infiltration. These underexplored impacts of gene manipulation provide new opportunities for development of bioinspired materials to aid the migration of replacement cells into retinal host. This has high clinical relevance because it indicates that biomaterials can be paired to genetically modified Top2b cells to augment cell migration into host retina. This is a highly underexplored first step in achieving the integration desired via transplantation. We also note that while Top2b was used as a model in our study, the data highlight selective pairing of ECM components with cells modified for specific characteristics, in complement to development of compound biomaterials with properties that better mimic physiological conditions. Future study will apply established microfluidics-approach to visualize gene edited cell groups for the average size and distribution of cell clusters [<xref ref-type="bibr" rid="B25">25</xref>] and to evaluate how this collective modality can be enhanced or attenuated upon different biomaterial substrates. Future experiments will also utilize CRISPR technology to produce retinal progenitor cell groups with altered Top2b regulation for long term culture and transplantation study.</p>
<p id="p-41">In summary, development of transplantable materials is a crucial aspect of cell replacement therapy that must incorporate the modalities of cell behavior upon matrix substrates. Stem cell replacements for dysfunctional retinal neurons are increasingly gene-edited and/or manipulated, which often impacts cell-to-cell and cell-to-matrix responses needed to stimulate infiltration into retinal host. Bioinspired materials able to modulate the nature and modalities of adhesion and migratory responses of transplanted cells have great potential to advance transplantation outcomes.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Cdh2</term>
<def>
<p>cadherin 2</p>
</def>
</def-item>
<def-item>
<term>CIV</term>
<def>
<p>collagen IV</p>
</def>
</def-item>
<def-item>
<term>CMI</term>
<def>
<p>Cell Migration Index</p>
</def>
</def-item>
<def-item>
<term>CSI</term>
<def>
<p>Cell Shape Index</p>
</def>
</def-item>
<def-item>
<term>DPBS</term>
<def>
<p>Dulbecco’s phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term>E6</term>
<def>
<p>embryonic day 6</p>
</def>
</def-item>
<def-item>
<term>ECM</term>
<def>
<p>extracellular matrix</p>
</def>
</def-item>
<def-item>
<term>FGFR</term>
<def>
<p>fibroblast growth factor receptor</p>
</def>
</def-item>
<def-item>
<term>GCL</term>
<def>
<p>ganglion cell layer</p>
</def>
</def-item>
<def-item>
<term>INBL</term>
<def>
<p>inner neuroblastic layer</p>
</def>
</def-item>
<def-item>
<term>INL</term>
<def>
<p>inner nuclear layer</p>
</def>
</def-item>
<def-item>
<term>IPL</term>
<def>
<p>inner plexiform layer</p>
</def>
</def-item>
<def-item>
<term>LM</term>
<def>
<p>laminin</p>
</def>
</def-item>
<def-item>
<term>OCT</term>
<def>
<p>optimal cutting temperature</p>
</def>
</def-item>
<def-item>
<term>ONL</term>
<def>
<p>outer nuclear layer</p>
</def>
</def-item>
<def-item>
<term>OPL</term>
<def>
<p>outer plexiform layer</p>
</def>
</def-item>
<def-item>
<term>PBS</term>
<def>
<p>phosphate buffer saline</p>
</def>
</def-item>
<def-item>
<term>PFA</term>
<def>
<p>paraformaldehyde</p>
</def>
</def-item>
<def-item>
<term>PLL</term>
<def>
<p>poly-L-lysine</p>
</def>
</def-item>
<def-item>
<term>PST</term>
<def>
<p>polystyrene</p>
</def>
</def-item>
<def-item>
<term>SDF1-a</term>
<def>
<p>stromal derived factor 1-a</p>
</def>
</def-item>
<def-item>
<term>Top2b</term>
<def>
<p>Topoisomerase II beta</p>
</def>
</def-item>
<def-item>
<term>Top2b-KD</term>
<def>
<p>Topoisomerase II beta knockdown</p>
</def>
</def-item>
<def-item>
<term>Top2b-OE</term>
<def>
<p>Topoisomerase II beta overexpression</p>
</def>
</def-item>
<def-item>
<term>VEGFR</term>
<def>
<p>vascular endothelial growth factor receptor</p>
</def>
</def-item>
</def-list>
</glossary>
<sec id="s-suppl" sec-type="supplementary-material">
<title>Supplementary materials</title>
<p>The supplementary figure for this article is available at: <uri xlink:href="https://www.explorationpub.com/uploads/Article/file/101335_sup_1.pdf">https://www.explorationpub.com/uploads/Article/file/101335_sup_1.pdf</uri>.</p>
<supplementary-material id="SD1" content-type="local-data">
<media xlink:href="101335_sup_1.pdf" mimetype="application" mime-subtype="pdf"></media>
</supplementary-material>
</sec>
<sec id="s6">
<title>Declarations</title>
<sec id="t-6-1">
<title>Acknowledgements</title>
<p>The co-authors thank Ms. Larissa Oprysk for her contributions to the development of figures.</p>
</sec>
<sec id="t-6-2">
<title>Author contributions</title>
<p>ACD, ARL, BR: Validation, Writing—review &amp; editing. RR: Data curation. LC: Conceptualization, Writing—review &amp; editing. MV: Conceptualization, Supervision, Writing—original draft, Writing—review &amp; editing. All authors read and approved the submitted version.</p>
</sec>
<sec id="t-6-3" sec-type="COI-statement">
<title>Conflicts of interest</title>
<p>The authors declare that they have no conflicts of interest.</p>
</sec>
<sec id="t-6-4">
<title>Ethical approval</title>
<p>All of the animal experiments were waived by the Institutional Animal Care and Facilities Committee at Rutgers University. Chick embryos up to embryonic day 18 (E18) are not considered vertebrates by the Institutional Animal Care and Facilities Committee (IACUC) at Rutgers University. Thus, the embryos (E1–E12) studied in this project are not subject to IACUC approval.</p>
</sec>
<sec id="t-6-5">
<title>Consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec id="t-6-6">
<title>Consent to publication</title>
<p>Not applicable.</p>
</sec>
<sec id="t-6-7" sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.</p>
</sec>
<sec id="t-6-8">
<title>Funding</title>
<p>This work was supported by the National Institutes of Health [R21 EY031439-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</sec>
<sec id="t-6-9">
<title>Copyright</title>
<p>© The Author(s) 2025.</p>
</sec>
</sec>
<sec id="s7">
<title>Publisher’s note</title>
<p>Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>GBD 2019 Blindness and Vision Impairment Collaborators</collab>
<collab>Vision Loss Expert Group of the Global Burden of Disease Study</collab>
</person-group>
<article-title>Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study</article-title>
<source>Lancet Glob Health</source>
<year iso-8601-date="2021">2021</year>
<volume>9</volume>
<fpage>e144</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/S2214-109X(20)30489-7</pub-id>
<pub-id pub-id-type="pmid">33275949</pub-id>
<pub-id pub-id-type="pmcid">PMC7820391</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teo</surname>
<given-names>ZL</given-names>
</name>
<name>
<surname>Tham</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chee</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Rim</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>N</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis</article-title>
<source>Ophthalmology</source>
<year iso-8601-date="2021">2021</year>
<volume>128</volume>
<fpage>1580</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.ophtha.2021.04.027</pub-id>
<pub-id pub-id-type="pmid">33940045</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van</surname>
<given-names>Gelder RN</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Dyer</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Greenwell</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>RO</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Regenerative and restorative medicine for eye disease</article-title>
<source>Nat Med</source>
<year iso-8601-date="2022">2022</year>
<volume>28</volume>
<fpage>1149</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-022-01862-8</pub-id>
<pub-id pub-id-type="pmid">35715505</pub-id>
<pub-id pub-id-type="pmcid">PMC10718186</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives</article-title>
<source>Biomedicines</source>
<year iso-8601-date="2021">2021</year>
<volume>9</volume>
<elocation-id>1203</elocation-id>
<pub-id pub-id-type="doi">10.3390/biomedicines9091203</pub-id>
<pub-id pub-id-type="pmid">34572389</pub-id>
<pub-id pub-id-type="pmcid">PMC8471559</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dromel</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Likes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kurisawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alexander-Katz</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy</article-title>
<source>NPJ Regen Med</source>
<year iso-8601-date="2021">2021</year>
<volume>6</volume>
<elocation-id>85</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41536-021-00195-3</pub-id>
<pub-id pub-id-type="pmid">34930951</pub-id>
<pub-id pub-id-type="pmcid">PMC8688498</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jemni-Damer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Guedan-Duran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cichy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lozano-Picazo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gonzalez-Nieto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perez-Rigueiro</surname>
<given-names>J</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>First steps for the development of silk fibroin-based 3D biohybrid retina for age-related macular degeneration (AMD)</article-title>
<source>J Neural Eng</source>
<year iso-8601-date="2020">2020</year>
<volume>17</volume>
<elocation-id>055003</elocation-id>
<pub-id pub-id-type="doi">10.1088/1741-2552/abb9c0</pub-id>
<pub-id pub-id-type="pmid">32947273</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kundu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Michaelson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baranov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Carrier</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Decellularized retinal matrix: Natural platforms for human retinal progenitor cell culture</article-title>
<source>Acta Biomater</source>
<year iso-8601-date="2016">2016</year>
<volume>31</volume>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.actbio.2015.11.028</pub-id>
<pub-id pub-id-type="pmid">26621699</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Acellularized Uvea Hydrogel as Novel Injectable Platform for Cell-Based Delivering Treatment of Retinal Degeneration and Optimizing Retinal Organoids Inducible System</article-title>
<source>Adv Healthc Mater</source>
<year iso-8601-date="2022">2022</year>
<volume>11</volume>
<elocation-id>e2202114</elocation-id>
<pub-id pub-id-type="doi">10.1002/adhm.202202114</pub-id>
<pub-id pub-id-type="pmid">36189847</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasseville</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tchatchouang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Charpentier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gobert</surname>
<given-names>D</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Biomaterials used for tissue engineering of barrier-forming cell monolayers in the eye</article-title>
<source>Front Bioeng Biotechnol</source>
<year iso-8601-date="2023">2023</year>
<volume>11</volume>
<elocation-id>1269385</elocation-id>
<pub-id pub-id-type="doi">10.3389/fbioe.2023.1269385</pub-id>
<pub-id pub-id-type="pmid">37840667</pub-id>
<pub-id pub-id-type="pmcid">PMC10569698</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>DSR</given-names>
</name>
<name>
<surname>Seiler</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Camarillo</surname>
<given-names>JCM</given-names>
</name>
<name>
<surname>Humayun</surname>
<given-names>MS</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Tissue Engineering Strategies for Retina Regeneration</article-title>
<source>Appl Sci (Basel)</source>
<year iso-8601-date="2021">2021</year>
<volume>11</volume>
<elocation-id>2154</elocation-id>
<pub-id pub-id-type="doi">10.3390/app11052154</pub-id>
<pub-id pub-id-type="pmid">35251703</pub-id>
<pub-id pub-id-type="pmcid">PMC8896578</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Luz-Madrigal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>J</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Micromolded honeycomb scaffold design to support the generation of a bilayered RPE and photoreceptor cell construct</article-title>
<source>Bioact Mater</source>
<year iso-8601-date="2023">2023</year>
<volume>30</volume>
<fpage>142</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.bioactmat.2023.07.019</pub-id>
<pub-id pub-id-type="pmid">37575875</pub-id>
<pub-id pub-id-type="pmcid">PMC10415596</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soucy</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Aguzzi</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gilhooley</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Keuthan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium</article-title>
<source>Mol Neurodegener</source>
<year iso-8601-date="2023">2023</year>
<volume>18</volume>
<elocation-id>64</elocation-id>
<pub-id pub-id-type="doi">10.1186/s13024-023-00655-y</pub-id>
<pub-id pub-id-type="pmid">37735444</pub-id>
<pub-id pub-id-type="pmcid">PMC10514988</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Mullins</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Sulchek</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Microfluidic processing of stem cells for autologous cell replacement</article-title>
<source>Stem Cells Transl Med</source>
<year iso-8601-date="2021">2021</year>
<volume>10</volume>
<fpage>1384</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1002/sctm.21-0080</pub-id>
<pub-id pub-id-type="pmid">34156760</pub-id>
<pub-id pub-id-type="pmcid">PMC8459636</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Musa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kantor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McClements</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Cehajic-Kapetanovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>MacLaren</surname>
<given-names>RE</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Genome-Editing Strategies for Treating Human Retinal Degenerations</article-title>
<source>Hum Gene Ther</source>
<year iso-8601-date="2021">2021</year>
<volume>32</volume>
<fpage>247</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1089/hum.2020.231</pub-id>
<pub-id pub-id-type="pmid">32993386</pub-id>
<pub-id pub-id-type="pmcid">PMC7987357</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Hallam</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chichagova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Steel</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Lako</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Application of Biomaterials to Tissue Engineering Neural Retina and Retinal Pigment Epithelium</article-title>
<source>Adv Healthc Mater</source>
<year iso-8601-date="2018">2018</year>
<volume>7</volume>
<elocation-id>e1800226</elocation-id>
<pub-id pub-id-type="doi">10.1002/adhm.201800226</pub-id>
<pub-id pub-id-type="pmid">30175520</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Targeting collective behaviors of transplanted retinal cells as a strategy to improve cellular integration</article-title>
<source>Neural Regen Res</source>
<year iso-8601-date="2022">2022</year>
<volume>17</volume>
<fpage>1271</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.327345</pub-id>
<pub-id pub-id-type="pmid">34782569</pub-id>
<pub-id pub-id-type="pmcid">PMC8643041</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warre-Cornish</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sowden</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Migration, integration and maturation of photoreceptor precursors following transplantation in the mouse retina</article-title>
<source>Stem Cells Dev</source>
<year iso-8601-date="2014">2014</year>
<volume>23</volume>
<fpage>941</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2013.0471</pub-id>
<pub-id pub-id-type="pmid">24328605</pub-id>
<pub-id pub-id-type="pmcid">PMC3996938</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pena</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Redenti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Majeska</surname>
<given-names>R</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Collective adhesion and displacement of retinal progenitor cells upon extracellular matrix substrates of transplantable biomaterials</article-title>
<source>J Tissue Eng</source>
<year iso-8601-date="2018">2018</year>
<volume>9</volume>
<elocation-id>2041731417751286</elocation-id>
<pub-id pub-id-type="doi">10.1177/2041731417751286</pub-id>
<pub-id pub-id-type="pmid">29344334</pub-id>
<pub-id pub-id-type="pmcid">PMC5764132</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCutcheon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Unachukwu</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Thakur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Majeska</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Redenti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>In vitro formation of neuroclusters in microfluidic devices and cell migration as a function of stromal-derived growth factor 1 gradients</article-title>
<source>Cell Adh Migr</source>
<year iso-8601-date="2017">2017</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1080/19336918.2015.1131388</pub-id>
<pub-id pub-id-type="pmid">26744909</pub-id>
<pub-id pub-id-type="pmcid">PMC5308225</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pena</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Majeska</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Invertebrate Retinal Progenitors as Regenerative Models in a Microfluidic System</article-title>
<source>Cells</source>
<year iso-8601-date="2019">2019</year>
<volume>8</volume>
<elocation-id>1301</elocation-id>
<pub-id pub-id-type="doi">10.3390/cells8101301</pub-id>
<pub-id pub-id-type="pmid">31652654</pub-id>
<pub-id pub-id-type="pmcid">PMC6829900</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schnichels</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Paquet-Durand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Löscher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Joachim</surname>
<given-names>SC</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina</article-title>
<source>Prog Retin Eye Res</source>
<year iso-8601-date="2021">2021</year>
<volume>81</volume>
<elocation-id>100880</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.preteyeres.2020.100880</pub-id>
<pub-id pub-id-type="pmid">32721458</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>YV</given-names>
</name>
<name>
<surname>Sodhi</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Agakishiev</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McNally</surname>
<given-names>MM</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Quantifiable In Vivo Imaging Biomarkers of Retinal Regeneration by Photoreceptor Cell Transplantation</article-title>
<source>Transl Vis Sci Technol</source>
<year iso-8601-date="2020">2020</year>
<volume>9</volume>
<elocation-id>5</elocation-id>
<pub-id pub-id-type="doi">10.1167/tvst.9.7.5</pub-id>
<pub-id pub-id-type="pmid">32832212</pub-id>
<pub-id pub-id-type="pmcid">PMC7414711</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peña</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Harnessing the Neuroprotective Behaviors of Müller Glia for Retinal Repair</article-title>
<source>Front Biosci (Landmark Ed)</source>
<year iso-8601-date="2022">2022</year>
<volume>27</volume>
<elocation-id>169</elocation-id>
<pub-id pub-id-type="doi">10.31083/j.fbl2706169</pub-id>
<pub-id pub-id-type="pmid">35748245</pub-id>
<pub-id pub-id-type="pmcid">PMC9639582</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Evaluation of ganglion cell-inner plexiform layer thickness in the diagnosis of pre-perimetric glaucoma and comparison to retinal nerve fiber layers</article-title>
<source>Indian J Ophthalmol</source>
<year iso-8601-date="2024">2024</year>
<volume>72</volume>
<fpage>357</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.4103/IJO.IJO_939_23</pub-id>
<pub-id pub-id-type="pmid">38099576</pub-id>
<pub-id pub-id-type="pmcid">PMC11001225</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microfluidic and Microscale Assays to Examine Regenerative Strategies in the Neuro Retina</article-title>
<source>Micromachines (Basel)</source>
<year iso-8601-date="2020">2020</year>
<volume>11</volume>
<elocation-id>1089</elocation-id>
<pub-id pub-id-type="doi">10.3390/mi11121089</pub-id>
<pub-id pub-id-type="pmid">33316971</pub-id>
<pub-id pub-id-type="pmcid">PMC7763644</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behtaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Öchsner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anissimov</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Rybachuk</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma</article-title>
<source>Tissue Eng Regen Med</source>
<year iso-8601-date="2020">2020</year>
<volume>17</volume>
<fpage>253</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1007/s13770-020-00254-8</pub-id>
<pub-id pub-id-type="pmid">32390117</pub-id>
<pub-id pub-id-type="pmcid">PMC7260329</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ladero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reche-Sainz</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gallardo</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells</article-title>
<source>Bioengineering (Basel)</source>
<year iso-8601-date="2024">2024</year>
<volume>11</volume>
<elocation-id>52</elocation-id>
<pub-id pub-id-type="doi">10.3390/bioengineering11010052</pub-id>
<pub-id pub-id-type="pmid">38247929</pub-id>
<pub-id pub-id-type="pmcid">PMC10813088</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Austin</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Swan</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Khazeem</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Manville</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cridland</surname>
<given-names>P</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>TOP2B: The First Thirty Years</article-title>
<source>Int J Mol Sci</source>
<year iso-8601-date="2018">2018</year>
<volume>19</volume>
<elocation-id>2765</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19092765</pub-id>
<pub-id pub-id-type="pmid">30223465</pub-id>
<pub-id pub-id-type="pmcid">PMC6163646</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Azarova</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>Role of topoisomerase IIbeta in the expression of developmentally regulated genes</article-title>
<source>Mol Cell Biol</source>
<year iso-8601-date="2006">2006</year>
<volume>26</volume>
<fpage>7929</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00617-06</pub-id>
<pub-id pub-id-type="pmid">16923961</pub-id>
<pub-id pub-id-type="pmcid">PMC1636731</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year iso-8601-date="2003">2003</year>
<volume>100</volume>
<fpage>7123</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1232376100</pub-id>
<pub-id pub-id-type="pmid">12773624</pub-id>
<pub-id pub-id-type="pmcid">PMC165840</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmond</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hanley</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Philippidou</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Topoisomerase IIβ Selectively Regulates Motor Neuron Identity and Peripheral Connectivity through Hox/Pbx-Dependent Transcriptional Programs</article-title>
<source>eNeuro</source>
<year iso-8601-date="2017">2017</year>
<volume>4</volume>
<fpage>ENEURO.0404</fpage>
<lpage>17.2017</lpage>
<pub-id pub-id-type="doi">10.1523/ENEURO.0404-17.2017</pub-id>
<pub-id pub-id-type="pmid">29379870</pub-id>
<pub-id pub-id-type="pmcid">PMC5779120</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhanothu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kondapi</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Status of topoisomerase-2β protein in all-trans retinoic acid-treated human neuroblastoma (SK-N-SH) cells</article-title>
<source>J Cell Biochem</source>
<year iso-8601-date="2019">2019</year>
<volume>120</volume>
<fpage>5169</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.27793</pub-id>
<pub-id pub-id-type="pmid">30318608</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tzatzalos</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Doh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>LF</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Topoisomerase IIbeta is required for proper retinal development and survival of postmitotic cells</article-title>
<source>Biol Open</source>
<year iso-8601-date="2014">2014</year>
<volume>3</volume>
<fpage>172</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1242/bio.20146767</pub-id>
<pub-id pub-id-type="pmid">24463367</pub-id>
<pub-id pub-id-type="pmcid">PMC3925320</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Swerdel</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>RP</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Top2b is involved in the formation of outer segment and synapse during late-stage photoreceptor differentiation by controlling key genes of photoreceptor transcriptional regulatory network</article-title>
<source>J Neurosci Res</source>
<year iso-8601-date="2017">2017</year>
<volume>95</volume>
<fpage>1951</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.24037</pub-id>
<pub-id pub-id-type="pmid">28370415</pub-id>
<pub-id pub-id-type="pmcid">PMC5561520</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doh</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tawil</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DK</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Analysis of retinal cell development in chick embryo by immunohistochemistry and in ovo electroporation techniques</article-title>
<source>BMC Dev Biol</source>
<year iso-8601-date="2010">2010</year>
<volume>10</volume>
<elocation-id>8</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-213X-10-8</pub-id>
<pub-id pub-id-type="pmid">20089190</pub-id>
<pub-id pub-id-type="pmcid">PMC2822752</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islam</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Doh</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>In ovo electroporation in embryonic chick retina</article-title>
<source>J Vis Exp</source>
<year iso-8601-date="2012">2012</year>
<volume>3792</volume>
<pub-id pub-id-type="doi">10.3791/3792</pub-id>
<pub-id pub-id-type="pmid">22330044</pub-id>
<pub-id pub-id-type="pmcid">PMC3369636</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grauslund</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thougaard</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Füchtbauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hofland</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Hjorth</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>PB</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo</article-title>
<source>Mol Pharmacol</source>
<year iso-8601-date="2007">2007</year>
<volume>72</volume>
<fpage>1003</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1124/mol.107.036970</pub-id>
<pub-id pub-id-type="pmid">17622580</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giménez-Abián</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Analyzing Mitotic Chromosome Structural Defects After Topoisomerase II Inhibition or Mutation</article-title>
<source>Methods Mol Biol</source>
<year iso-8601-date="2018">2018</year>
<volume>1703</volume>
<fpage>191</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-7459-7_15</pub-id>
<pub-id pub-id-type="pmid">29177744</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jirkovská</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Karabanovich</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kubeš</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Skalická</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Melnikova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Korábečný</surname>
<given-names>J</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions</article-title>
<source>J Med Chem</source>
<year iso-8601-date="2021">2021</year>
<volume>64</volume>
<fpage>3997</fpage>
<lpage>4019</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c02157</pub-id>
<pub-id pub-id-type="pmid">33750129</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons</article-title>
<source>Mol Neurodegener</source>
<year iso-8601-date="2012">2012</year>
<volume>7</volume>
<elocation-id>4</elocation-id>
<pub-id pub-id-type="doi">10.1186/1750-1326-7-4</pub-id>
<pub-id pub-id-type="pmid">22296971</pub-id>
<pub-id pub-id-type="pmcid">PMC3359158</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harkin</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Gerrelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>DCG</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alzu’bi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>CA</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon</article-title>
<source>J Anat</source>
<year iso-8601-date="2016">2016</year>
<volume>228</volume>
<fpage>452</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1111/joa.12416</pub-id>
<pub-id pub-id-type="pmid">26612825</pub-id>
<pub-id pub-id-type="pmcid">PMC4832326</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nur-E-Kamal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meiners</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Azarova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>YL</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Role of DNA topoisomerase IIbeta in neurite outgrowth</article-title>
<source>Brain Res</source>
<year iso-8601-date="2007">2007</year>
<volume>1154</volume>
<fpage>50</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2007.04.029</pub-id>
<pub-id pub-id-type="pmid">17493591</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsutsui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tokunaga</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Involvement of DNA topoisomerase IIbeta in neuronal differentiation</article-title>
<source>J Biol Chem</source>
<year iso-8601-date="2001">2001</year>
<volume>276</volume>
<fpage>5769</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M008517200</pub-id>
<pub-id pub-id-type="pmid">11106659</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comelles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Castillo-Fernández</surname>
<given-names>Ó</given-names>
</name>
<name>
<surname>Martínez</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>How to Get Away with Gradients</article-title>
<source>Adv Exp Med Biol</source>
<year iso-8601-date="2022">2022</year>
<volume>1379</volume>
<fpage>31</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1007/978-3-031-04039-9_2</pub-id>
<pub-id pub-id-type="pmid">35760987</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakula</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Balcerak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smietanka</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Chmielarczyk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Konopiński</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Grzybowska</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Quantification of Cell-Substrate Adhesion Area and Cell Shape Distributions in MCF7 Cell Monolayers</article-title>
<source>J Vis Exp</source>
<year iso-8601-date="2020">2020</year>
<volume>e61461</volume>
<pub-id pub-id-type="doi">10.3791/61461</pub-id>
<pub-id pub-id-type="pmid">32658197</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>
<source>Methods</source>
<year iso-8601-date="2001">2001</year>
<volume>25</volume>
<fpage>402</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
<pub-id pub-id-type="pmid">11846609</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergara</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Canto-Soler</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Rediscovering the chick embryo as a model to study retinal development</article-title>
<source>Neural Dev</source>
<year iso-8601-date="2012">2012</year>
<volume>7</volume>
<elocation-id>22</elocation-id>
<pub-id pub-id-type="doi">10.1186/1749-8104-7-22</pub-id>
<pub-id pub-id-type="pmid">22738172</pub-id>
<pub-id pub-id-type="pmcid">PMC3541172</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Grabowski</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>LL</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Topoisomerase II poisoning by ICRF-193</article-title>
<source>J Biol Chem</source>
<year iso-8601-date="2001">2001</year>
<volume>276</volume>
<fpage>44488</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M104383200</pub-id>
<pub-id pub-id-type="pmid">11577077</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caccamo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Katsetos</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Frankfurter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Immunohistochemistry of a spontaneous murine ovarian teratoma with neuroepithelial differentiation. Neuron-associated beta-tubulin as a marker for primitive neuroepithelium</article-title>
<source>Lab Invest</source>
<year iso-8601-date="1989">1989</year>
<volume>60</volume>
<fpage>390</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">2467076</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weishaupt</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Klöcker</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bähr</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells</article-title>
<source>J Mol Neurosci</source>
<year iso-8601-date="2005">2005</year>
<volume>26</volume>
<fpage>17</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1385/JMN:26:1:017</pub-id>
<pub-id pub-id-type="pmid">15968082</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Khare</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cepko</surname>
<given-names>CL</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>All Brn3 genes can promote retinal ganglion cell differentiation in the chick</article-title>
<source>Development</source>
<year iso-8601-date="2000">2000</year>
<volume>127</volume>
<fpage>3237</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1242/dev.127.15.3237</pub-id>
<pub-id pub-id-type="pmid">10887080</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Two calcium-binding proteins mark many chick sensory neurons</article-title>
<source>Neuroscience</source>
<year iso-8601-date="1989">1989</year>
<volume>31</volume>
<fpage>697</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(89)90434-x</pub-id>
<pub-id pub-id-type="pmid">2594198</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araki</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Britto</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Lindstrom</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Karten</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Hamassaki-Britto</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Differential co-localization of nicotinic acetylcholine receptor subunits with calcium-binding proteins in retinal ganglion cells</article-title>
<source>Brain Res</source>
<year iso-8601-date="1997">1997</year>
<volume>774</volume>
<fpage>250</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/s0006-8993(97)81715-5</pub-id>
<pub-id pub-id-type="pmid">9452220</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Spatio-temporally restricted expression of cell adhesion molecules during chicken embryonic development</article-title>
<source>PLoS One</source>
<year iso-8601-date="2014">2014</year>
<volume>9</volume>
<elocation-id>e96837</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0096837</pub-id>
<pub-id pub-id-type="pmid">24806091</pub-id>
<pub-id pub-id-type="pmcid">PMC4013082</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seigel</surname>
<given-names>GM</given-names>
</name>
</person-group>
<article-title>Review: R28 retinal precursor cells: the first 20 years</article-title>
<source>Mol Vis</source>
<year iso-8601-date="2014">2014</year>
<volume>20</volume>
<fpage>301</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">24644404</pub-id>
<pub-id pub-id-type="pmcid">PMC3955414</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Treharne</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Grossel</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lotery</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>The chemistry of retinal transplantation: the influence of polymer scaffold properties on retinal cell adhesion and control</article-title>
<source>Br J Ophthalmol</source>
<year iso-8601-date="2011">2011</year>
<volume>95</volume>
<fpage>768</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.2010.184002</pub-id>
<pub-id pub-id-type="pmid">20807710</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Benelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Alarfaj</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Munusamy</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Umezawa</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Stem Cell Therapies for Reversing Vision Loss</article-title>
<source>Trends Biotechnol</source>
<year iso-8601-date="2017">2017</year>
<volume>35</volume>
<fpage>1102</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibtech.2017.06.016</pub-id>
<pub-id pub-id-type="pmid">28751147</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Cell micropatterning reveals the modulatory effect of cell shape on proliferation through intracellular calcium transients</article-title>
<source>Biochim Biophys Acta Mol Cell Res</source>
<year iso-8601-date="2017">2017</year>
<volume>1864</volume>
<fpage>2389</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2017.09.015</pub-id>
<pub-id pub-id-type="pmid">28962833</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sluch</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Chamling</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Berlinicke</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>KL</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Enhanced Stem Cell Differentiation and Immunopurification of Genome Engineered Human Retinal Ganglion Cells</article-title>
<source>Stem Cells Transl Med</source>
<year iso-8601-date="2017">2017</year>
<volume>6</volume>
<fpage>1972</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1002/sctm.17-0059</pub-id>
<pub-id pub-id-type="pmid">29024560</pub-id>
<pub-id pub-id-type="pmcid">PMC6430043</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Prescott</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Burden</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>DNA topoisomerase IIbeta and neural development</article-title>
<source>Science</source>
<year iso-8601-date="2000">2000</year>
<volume>287</volume>
<fpage>131</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1126/science.287.5450.131</pub-id>
<pub-id pub-id-type="pmid">10615047</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nevin</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Staub</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Baier</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Topoisomerase IIbeta is required for lamina-specific targeting of retinal ganglion cell axons and dendrites</article-title>
<source>Development</source>
<year iso-8601-date="2011">2011</year>
<volume>138</volume>
<fpage>2457</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1242/dev.060335</pub-id>
<pub-id pub-id-type="pmid">21610027</pub-id>
<pub-id pub-id-type="pmcid">PMC3100707</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hossain</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Akimitsu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sekimizu</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>ICRF-193, a catalytic inhibitor of DNA topoisomerase II, inhibits re-entry into the cell division cycle from quiescent state in mammalian cells</article-title>
<source>Genes Cells</source>
<year iso-8601-date="2002">2002</year>
<volume>7</volume>
<fpage>285</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2443.2002.00521.x</pub-id>
<pub-id pub-id-type="pmid">11918672</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakazawa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mehrotra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yanagida</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>ICRF-193, an anticancer topoisomerase II inhibitor, induces arched telophase spindles that snap, leading to a ploidy increase in fission yeast</article-title>
<source>Genes Cells</source>
<year iso-8601-date="2016">2016</year>
<volume>21</volume>
<fpage>978</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1111/gtc.12397</pub-id>
<pub-id pub-id-type="pmid">27458047</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eiraku</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sakakura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>S</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Self-organizing optic-cup morphogenesis in three-dimensional culture</article-title>
<source>Nature</source>
<year iso-8601-date="2011">2011</year>
<volume>472</volume>
<fpage>51</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1038/nature09941</pub-id>
<pub-id pub-id-type="pmid">21475194</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Enriching new transplantable RGC-like cells from retinal organoids for RGC replacement therapy</article-title>
<source>Biochem Biophys Res Commun</source>
<year iso-8601-date="2024">2024</year>
<volume>700</volume>
<elocation-id>149509</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2024.149509</pub-id>
<pub-id pub-id-type="pmid">38306929</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Hara-Wright</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gonzalez-Cordero</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Retinal organoids: a window into human retinal development</article-title>
<source>Development</source>
<year iso-8601-date="2020">2020</year>
<volume>147</volume>
<elocation-id>dev189746</elocation-id>
<pub-id pub-id-type="doi">10.1242/dev.189746</pub-id>
<pub-id pub-id-type="pmid">33361444</pub-id>
<pub-id pub-id-type="pmcid">PMC7774906</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roll</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Faissner</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage</article-title>
<source>Front Cell Neurosci</source>
<year iso-8601-date="2014">2014</year>
<volume>8</volume>
<elocation-id>219</elocation-id>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00219</pub-id>
<pub-id pub-id-type="pmid">25191223</pub-id>
<pub-id pub-id-type="pmcid">PMC4137450</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>She</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Polybenzyl Glutamate Biocompatible Scaffold Promotes the Efficiency of Retinal Differentiation toward Retinal Ganglion Cell Lineage from Human-Induced Pluripotent Stem Cells</article-title>
<source>Int J Mol Sci</source>
<year iso-8601-date="2019">2019</year>
<volume>20</volume>
<elocation-id>178</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20010178</pub-id>
<pub-id pub-id-type="pmid">30621308</pub-id>
<pub-id pub-id-type="pmcid">PMC6337229</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mood</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Battu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Daar</surname>
<given-names>IO</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor receptor-induced phosphorylation of ephrinB1 modulates its interaction with Dishevelled</article-title>
<source>Mol Biol Cell</source>
<year iso-8601-date="2009">2009</year>
<volume>20</volume>
<fpage>124</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.e08-06-0662</pub-id>
<pub-id pub-id-type="pmid">19005214</pub-id>
<pub-id pub-id-type="pmcid">PMC2613129</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unachukwu</surname>
<given-names>UJ</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sauane</surname>
<given-names>M</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Predicted molecular signaling guiding photoreceptor cell migration following transplantation into damaged retina</article-title>
<source>Sci Rep</source>
<year iso-8601-date="2016">2016</year>
<volume>6</volume>
<elocation-id>22392</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep22392</pub-id>
<pub-id pub-id-type="pmid">26935401</pub-id>
<pub-id pub-id-type="pmcid">PMC4776098</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markey</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Pena</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Retinal Progenitor Cells Exhibit Cadherin-Dependent Chemotaxis across Transplantable Extracellular Matrix of In Vitro Developmental and Adult Models</article-title>
<source>J Tissue Eng Regener Med</source>
<year iso-8601-date="2023">2023</year>
<volume>2023</volume>
<elocation-id>1381620</elocation-id>
<pub-id pub-id-type="doi">10.1155/2023/1381620</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>